Senna Syrup (sennosides) 8.8 mg, 8 fl. oz. (237 mL) bottle, Distributed by: Major Pharmaceuticals...

FDA Drug Recall #D-1526-2016 — Class II — August 8, 2016

Recall Summary

Recall Number D-1526-2016
Classification Class II — Moderate risk
Date Initiated August 8, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Pharmatech LLC
Location Davie, FL
Product Type Drugs
Quantity 68,908 bottles

Product Description

Senna Syrup (sennosides) 8.8 mg, 8 fl. oz. (237 mL) bottle, Distributed by: Major Pharmaceuticals, 31778 Enterprise Drive, Livonia, MI 48150, NDC 0904-6289-09.

Reason for Recall

CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.

Distribution Pattern

Nationwide

Lot / Code Information

Lot #: 20391517, Exp 09/17; 20391518, Exp10/17; 20391519, Exp 11/17; 20391601, Exp 01/18; 20391602, Exp 02/18; 20391604, 20391605, Exp 03/18; 20391608, Exp 06/18

Other Recalls from Pharmatech LLC

Recall # Classification Product Date
D-0227-2018 Class II Rugby Aller-chlor (Chlorpheniramine Maleate Syr... Aug 16, 2017
D-0225-2018 Class II Rugby Diocto Syrup, Docusate Sodium 60 mg/15 mL... Aug 16, 2017
D-0224-2018 Class II Rugby Diocto Liquid, Docusate Sodium 50 mg/ 5 m... Aug 16, 2017
D-0226-2018 Class II Rugby Senexon Liquid Natural Vegetable Stimulan... Aug 16, 2017
D-1524-2016 Class II Diocto Syrup (docusate sodium), 60 mg/15 mL, On... Aug 8, 2016

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.